HOLLO LIMITED

Hollo is a health-tech company founded in Hong Kong, supported by the likes of Microsoft, Cyberport, HK ITF, and the SIE Fund HK (HK Government). A platform of clinical-grade Digital Therapeutics, driven by Behavioral Health AI to treat the mental health of chronic patients. By creating accessible measurement and treatment tools, Hollo integrates with Healthcare providers to incentivize stickier treatments and gamify the patient data recording and digital treatment process. By holding our product up to FDA approval standards, Hollo aims to be the first Asian-focused Digital Therapeutics company to be approved by the FDA for treating comorbid Chronic Illness and Mental Health.